Learning Treatment Allocations with Risk Control Under Partial Identifiability
Sofia Ek, Dave Zachariah
ICML 2026 regular
Abstract (source: OpenReview · © authors)
Learning beneficial treatment allocations for a patient population is an important problem in precision medicine. For such allocations, a certain proportion of treated patients may not receive any benefit. This proportion of unnecessary treated represents a `treatment risk' which is a waste of resources and may, in addition, expose patients to unnecessary adverse effects. Therefore, we aim to control the treatment risk when learning beneficial allocations. This learning problem is complicated by the fact that the treatment risk is generally not identifiable from either randomized trial or observational data. We propose a certifiable learning method that controls treatment risk, using finite samples in the partially identified setting. The method is illustrated using both simulated and real data.
Keywords
Metadata from BioTender-max/icml2026-ai-bio (CC0-1.0). Phở does not host any PDF; links point back to the source.
Related
ClinTutor-R1: Advancing Scalable and Robust One-to-Many Alignment in Clinical Socratic Education
Zhitao He, Haolin Yang, Zeyu Qin, Yi R. Fung
While Large Language Models (LLMs) have achieved remarkable success in dyadic (one-on-one) instruction, they face significant challenges in One-to-Many alignment, such as clinical…
HypoSpace: A Diagnostic Benchmark for Set-Valued Hypothesis Generation under Underdetermination and Sublinear Coverage Bounds
Tingting Chen, Beibei Lin, Zifeng Yuan, Qiran Zou +4
Many scientific problems are underdetermined: multiple distinct hypotheses are equally consistent with the same observations. In such settings, effective inference requires not…
Listening Through the Noise: Cauchy-Driven Diffusion Bridges for Robust Gastrointestinal Auscultation and Clinical Benchmarking
Dian Ding, Liren Dong, Yu Lu, Juntao Zhou +4
Gastrointestinal (GI) motility assessment via bowel sounds (BS) offers a non-invasive alternative to resource-intensive clinical standards. However, the diagnostic utility of BS…